Newsbot

» Nachrichtenticker öffnen

Xi, Putin Hail Opening of China-Russia Expo, Stress Cooperation

Chinese President Xi Jinping and Russian President Vladimir Putin exchanged congratulatory messages marking the opening of the China-Russia Expo in the northeasten city of Harbin, highlighting deepening economic ties between the two countries.

WHO Declares Congo Ebola Outbreak Global Health Emergency

The World Health Organization declared an Ebola outbreak in Democratic Republic of Congo and Uganda a public health emergency of international concern, warning that a rare virus strain with no approved vaccine or treatment may already be spreading more widely than detected.

Crypto News: AlphaPepe Presale Records Surge in Whale Accumulation As Bitcoin Price Prediction Eyes $180,000

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the project reported a surge in whale accumulation while Stage 16 remains live at $0.01717 per token. The presale has raised over $1.22 million, the holder count has passed 8,600, the AlphaSwap AI DEX demo has surpassed 4,000 active users, and the project has completed a full 10/10 BlockSAFU security audit ahead of its planned Q2 2026 exchange debut.

Genmab (CPSE:GMAB) Valuation Check After Recent Share Price Softness And 24.6% Undervaluation Estimate

Recent performance snapshot Genmab (CPSE:GMAB) has seen mixed share price moves recently, with the stock down about 1.7% on the day and lower over the past month and past 3 months, but higher over the past year. For context, Genmab reports revenue of 3,901 million DKK and net income of 821 million DKK from its antibody focused biotechnology business, and currently carries a market value of about 103.4b DKK. See our latest analysis for Genmab. At the current share price of DKK1,684.0, Genmab’s...

With high hopes, Yale continues to invest in Upper Science Hill

The University has poured hundreds of millions of dollars into the development of Upper Science Hill, which University leaders say will significantly improve research opportunities at Yale. The first phase is set to be completed this fall.

Jabil rated Buy with 32% upside on AI-driven margin growth and infrastructure demand

Jabil is rated Buy with a $450 price target, reflecting a 32% potential upside driven by strong demand for AI infrastructure and expected margin expansion. The companys operating margin is forecasted to increase from 5.7% in FY26 to over 6% in FY27, which will boost earnings per share growth. Jabils diversified portfolio, capacity expansion, and recent win with a third hyperscaler position it as a key beneficiary of the growing AI infrastructure market. This outlook highlights Jabils strategi...

Hims & Hers Health rebounds with growth, eyes $3B revenue by 2026 despite short-term margin pressures

Hims & Hers Health has returned to growth after a volatile period related to GLP-1 drug transitions. The company raised its revenue guidance for 2026 to $3 billion, surpassing analyst expectations, and this forecast does not yet include its recent Eucalyptus acquisition. While short-term margins face pressure from branded GLP-1 drugs and international expansion costs, Hims aims for at least 20% EBITDA margins by 2030. The stock trades near multi-year lows, offering potential upside as it targets...